Tesla Inc (NASDAQ:TSLA) shares jumped more than 8% following the successful launch of its autonomous Robotaxi service in Austin, Texas over the weekend.
The launch involved a limited pilot program featuring about 10 to 20 Model Y vehicles operating within a geofenced area in South Austin.
Compass Pathways (NASDAQ:CMPS) said its Phase 3 trial of its synthetic formulation of psilocybin, COMP360, in patients with treatment-resistant depression (TRD) met its primary endpoint.
A single 25mg dose of COMP360 demonstrated a statistically significant and meaningful reduction in depression symptom severity compared to placebo, with a mean difference of 3.6 points on the Montgomery-Åsberg Depression Rating Scale (MADRS) at week 6.
Shares of Hims & Hers Health (NYSE:HIMS) fell around 30% on Monday after Novo Nordisk (NYSE:NVO) terminated its collaboration with the telehealth company, citing violations related to compounding and marketing of the weight-loss drug Wegovy.
Novo said it ended Hims & Hers’ access to the FDA-approved treatment through its NovoCare platform, alleging that the company engaged in illegal mass compounding and deceptive marketing.
Circle Internet Group (NYSE:CRCL) shares surged more than 21% after it announced a strategic collaboration with Fiserv Inc (NYSE:FI) aimed at integrating stablecoin technology into mainstream financial services.
The partnership brings together Circle’s regulated USDC infrastructure and payments network with Fiserv’s extensive digital banking and payments capabilities, creating a powerful new channel for real-time, low-cost, and borderless stablecoin payments.
Shares in Thruvision Group PLC (AIM:THRU, OTC:DIGTF) fell 9% on Monday after the company warned it could run out of cash if expected sales fail to materialise. The stock is now down 88% so far this year.
The AIM-listed maker of walk-through security scanners said it has extended its cash runway to the end of September, based on several deals currently in final negotiations.